Production (Stage)
Ovation Science Inc.
OVATF
$0.0482
-$0.0002-0.41%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 81.22% | 34.86% | -10.81% | -56.81% | -56.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 81.22% | 34.86% | -10.81% | -56.81% | -56.83% |
| Cost of Revenue | 47.45% | 1,304.76% | 1,040.00% | 1,700.00% | 328.13% |
| Gross Profit | 95.64% | -10.34% | -42.96% | -83.80% | -68.83% |
| SG&A Expenses | -31.98% | -12.44% | -14.41% | -7.35% | -4.84% |
| Depreciation & Amortization | -33.33% | -8.33% | -25.00% | -42.86% | -53.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.44% | -17.16% | -18.59% | -8.77% | -9.66% |
| Operating Income | 38.36% | 22.88% | 19.69% | -0.36% | 0.87% |
| Income Before Tax | 45.64% | 19.91% | 18.79% | -9.57% | -0.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.64% | 19.91% | 18.79% | -9.57% | -0.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.64% | 19.91% | 18.79% | -9.57% | -0.83% |
| EBIT | 38.36% | 22.88% | 19.69% | -0.36% | 0.87% |
| EBITDA | 38.45% | 22.94% | 19.66% | -0.69% | 0.40% |
| EPS Basic | 51.47% | 29.50% | 24.63% | -3.09% | 1.92% |
| Normalized Basic EPS | 52.31% | 28.57% | 22.83% | -5.79% | 0.00% |
| EPS Diluted | 51.47% | 29.50% | 24.63% | -3.09% | 1.92% |
| Normalized Diluted EPS | 52.31% | 28.57% | 22.83% | -5.79% | 0.00% |
| Average Basic Shares Outstanding | 10.53% | 12.32% | 7.32% | 7.32% | 3.22% |
| Average Diluted Shares Outstanding | 10.53% | 12.32% | 7.32% | 7.32% | 3.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |